clinical trials and juvenile idiopathic arthritis (JIA) Archives

Abstract Number: 1679 • ACR/ARHP Annual Meeting 2012
Cumulative Long-Term Safety and Efficacy of Abatacept in Children with Juvenile Idiopathic Arthritis: Results up to 7 Years of Follow-up
D. J. Lovell¹, N. Ruperto², R. Mouy², E. Paz², N. Rubio-Perez², C. A. Silva², C. Abud-Mendoza², R. Burgos-Vargas², V. Gerloni², J. a. Melo-Gomes³, C. Saad-Magalhaes², J. Chavez⁴, C. Huemer², A. Kivitz², F. Blanco², I. Foeldvari², Michael Hofer⁵, H. Huppertz², C. Job Deslandre², K. Minden², A. Flores Nunez⁶, A. J. Block⁷ and A. Martini², ¹Cincinnati Children's Hospital, Cincinnati, OH, ²PRINTO, IRCCS G. Gaslini, Genoa, Italy, ³Pediatria II, Istituto Giannina Gaslini, Genoa, Italy, ⁴PRINTO, Genoa, Italy, ⁵Paediatric Rheumatology International Trials Organization (PRINTO), Istituto Giannina Gaslini, Genoa, Italy, ⁶PRINTO, IRCCS Hospital para el Niño Poblano, Puebla, Mexico, ⁷Bristol-Myers Squibb, Princeton, NJ
Background/Purpose: We previously reported the efficacy and safety of abatacept (ABA) in patients with juvenile idiopathic arthritis (JIA) in the AWAKEN trial1, during the 4-month…

Abstracts tagged "clinical trials and juvenile idiopathic arthritis (JIA)"